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ABSTRACT
Background: Ovalbumin, ovomucoid, ovotransferrin, lysozyme, and ovomucin are known to be major aller-
gens found in egg white. Egg white protein is composed of over 30 proteins; many of which have neither been
identified nor their allergenicities characterized. This study set out to analyze whether unknown proteins that
bind to IgE antibodies in serum from patients with egg allergy exist in egg white.
Methods: Diluted egg white proteins were separated by 2-dimensional (2-D) gel electrophoresis. Immunola-
beling was performed on individual patient sera from 19 child patients with egg white allergy and 11 negative
control subjects. Spots of egg white proteins that bound to the patients’ IgE were identified by mass
spectrometry-based proteomics.
Results: Egg white proteins were separated into 63 spots. Twenty-five of the 63 reacted with egg allergy pa-
tients’ sera, and 10 of the 25 reactive spots showed IgE-reactivity to controls as well. Specific bindings to the
IgE from egg allergy patients were found in 15 spots; one of which was confirmed as ovotransferrin. Among the
other 14 protein spots, egg white cystatin and lipocalin-type prostaglandin D synthase (L-PGDS) were newly
identified proteins that reacted with IgE in patients with egg allergy.
Conclusions: We demonstrated that L-PGDS and cystatin reacted with serum IgE in patients with egg al-
lergy. Our proteomics-based analysis in egg white gives a comprehensive map of proteins bound with IgE and
should assist in enabling more accurate diagnoses and recommendations of desensitizing treatments for indi-
vidual patients.
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cystatin, food allergy, hen’s egg white, LC-MSMS, lipocalin-type prostaglandin D synthase
ABBREVIATIONS
2-D, two dimensional; MALDI-TOFMS, matrix assisted laser desorption ionization time of flight mass spec-
trometry; LC-MSMS, liquid chromatographytandem mass spectrometry; L-PGDS, lipocalin-type
prostaglandin D synthase.
INTRODUCTION
Hen egg white, which is widely used in processed
foods, is one of the most common and serious causes
of immediate food allergic reactions in infants and
young children.1,2 This is because of their immature
gastrointestinal epithelial membrane barrier that al-
lows more proteins to enter the circulation.3,4 Egg al-
lergy induces vomiting, diarrhea, abdominal pain, ur-
ticaria, angioedema, acute rhinoconjunctivitis, cough,
wheezing, and anaphylactic shock. It is well known
that egg white protein is composed of over 30 pro-
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Table 1 Clinical characteristics and egg-white RAST scores in 19 patients with egg white alergy
RAST
egg 
white
Egg white IgE 
(UA/ml) 
Total IgE 
(IU/ml) 
Clinical reaction
SexAgePatient
Food chalengeReported episode
21.634.7Systemic anaphylaxis, urticariaF2SH
444.11347.5AngioedemaM4SK
35.4114.4UrticariaF1HS
311137.6Erythema, urticariaErythemaM1AO
310.6181.8Cough, wheezeM1RS
37.2509.9Abdominal pain, urticaria, 
cough
UrticariaM5TE
36.73326.4Urticaria, diarheaUrticariaF2AK
424.2741UrticariaUrticariaF4KM
311.3895.3UrticariaUrticariaM4RH
420.2630.4PruritusM2KK
10.555.3Dyspnea, vomiting, urticariaF2AS
33.9160Erythema, urticariaUrticaria, angioedemaM1YY
34181.4UrticariaF1MY
6>1001497.7DiarheaM0KS
21.3550ErythemaM6MT
315600ErythemaErythemaF1HM
22.5200Cough, pruritusErythemaM1KS
21.356UrticariaUrticariaM3SS
21.828ErythemaF0RY
GI, Gastrointestinal symptoms; resp, respiratory symptoms.
teins.5 The allergenicities of egg-white proteins, with
the exception of ovalbumin, ovomucoid, ovotransfer-
rin, lysozyme, and ovomucin have not been ana-
lyzed.6-8
Recently, new methods for analysis and characteri-
zation of proteins, including 2-D electrophoresis tech-
niques and mass spectrometry, have been devel-
oped.9-11 Liquid chromatographytandem mass spec-
trometry (LC-MSMS), or matrix assisted laser
desorption ionization time of flight mass spectrome-
try (MALDI-TOFMS), coupled with search engines
to access the huge amount of data produced by the
genome sequencing projects, has fueled the growth
of proteomics.12,13 Since spectra from only a few pep-
tides (or even a single peptide) can be sufficient to
identify a protein, new allergens have been reported
using these methods.14-17 It has also been reported
that the combined use of MALDI-TOF MS and LC-
MSMS has significantly increased the total number
of identified proteins.18,19
We sought to characterize any unknown egg white
allergens using proteomic approaches. Sixty spots
were visualized in egg white on 2-D gel using silver
stain. We then analyzed egg white proteins that
bound to serum IgE in patients with egg allergy on 2-
D immunoblots; two of the spots that bound to IgE
were subsequently newly identified by LC-MSMS
and were confirmed to react with IgE by immunola-
beling using each purified protein.
METHODS
SUBJECTS
Sera from 19 patients with egg allergy (aged 2.2 ± 1.7
years, total IgE 434.1 ± 424.7 IUml), and 11 negative
control subjects (4.0 ± 3.7 years) with no clinical his-
tory of any allergic symptoms were obtained and
stored in aliquots at -80℃ (Table 1). Informed con-
sent for the study was obtained from the parents of all
participating subjects before collecting blood, and the
protocol was approved by the Ethics Committee of
Gifu University School of Medicine. Diagnosis of egg
white allergy was based on clinical history and CAP-
RAST results to hen’s egg white.20 Food challenges
were performed in an open manner for 9 of the 19 pa-
tients without severe reactions. Our first challenge
dose was 140 of boiled egg white, and the dose was
doubled every 15 minutes until the patient exhibited
distinct symptoms or until 12 of the boiled egg white
was ingested. Clinical manifestations of egg allergy
for 16 of the 19 patients resulted in skin reactions,
which included urticaria (1119), erythema (519),
angioedema (219), and pruritus (119). Several pa-
tients had gastrointestinal (419) and respiratory (3
19) symptoms. Systemic anaphylaxis occurred in only
one patient (SH). Some patients were also sensitive to
other allergens such as those found in milk (58% of
patients), soybean (25%), wheat (37%), and mites
(21%) (unpublished data).
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Fig. 1 2-D proteomics map for egg white proteins. Egg white protein was sepa-
rated by 2-D electrophoresis. Silver staining was performed to visualize total 
protein. Molecular weight standards (MW) are shown on the left. OA, ovalbumin; 
OM, ovomucoid.
2-D GEL ELECTROPHORESIS
2-D gel electrophoresis was performed using modi-
fied protocols based on Görg et al.10 Egg white from
white leghorns was stirred for 40 minutes in 7 M
urea, 2 M thiourea, 1% NP-40, and 10 mM Tris-HCl.
Protein concentration was determined using a Bio-
Rad Protein Assay (Bio-Rad Laboratories, Hercules,
CA, USA), and egg white was diluted in lysis buffer
containing 7 M urea, 2 M thiourea, 4% CHAPS, 10
mM DTT, and 0.001% bromophenol blue. Diluted egg
white was applied to 7-cm immobilized pH3-10 non-
linear gradient strips (Amersham Bioscience,
Uppsala, Sweden). First-dimensional isoelectric fo-
cusing was performed at 20℃ for 16856 volt-hours us-
ing an Ettan IPGphor Isoelectric Focusing System
(Amersham Bioscience). After focusing, the gel
strips were equilibrated as described by Fujimura et
al.,15 although time of each equilibration step was
prolonged to 15 minutes. Proteins were subjected to
SDS-PAGE as described by Laemmli.21 Strips were
placed on top of 2-D 12% acrylamide gels (10 × 10 ×
0.1 cm slab). After migration, gels were fixed and
stained in 0.25% Coomasie blue R250, 50% methanol,
and 5% acetic acid or with a SilverQuest Silver Stain-
ing Kit (Invitrogen Life Technologies, Carlsbad, CA,
USA). The protein spots for the study were cut out
from acrylamide gel with a clean scalpel.
PROBING IMMUNOLABELING WITH SERUM
FROM ALLERGEN-SENSITIVE PATIENTS AND
CONTROLS
For the detection of IgE bound to separated egg
white proteins, immunolabeling was performed on
the patient sera sample from each of the 19 individu-
als with egg allergy and 11 control individuals. After
2-D PAGE, separated proteins were electroblotted
onto PVDF membrane (Amersham Bioscience UK
Ltd, Buckinghamshire, England) using a semidry
electrophoretic apparatus for 30 minutes at 15 V. The
membranes were blocked with 3% (wv) BSA in 50
mM Tris-HCl (pH 7.4) and 150 mM NaCl. After
blocking overnight at 4℃, patient and control sera
were diluted 4 times and were added to a washing so-
lution (0.1% Tween 20, 1% BSA) prior to being incu-
bated for 3 days at 4℃. After washing, the mem-
branes were incubated for 3 hours at room tempera-
ture with peroxidase-conjugated antibodies consist-
ing of goat antihuman IgE (KPL, Gaithersburg, MD,
USA) that had been diluted 1 : 2000 in washing solu-
tion. Protein spots resulting from immunolabeling
were visualized by reaction with an ECL-plus western
blotting detection reagent (Amersham Biosciences)
on X-ray film.
TRYPSIN IN-GEL DIGESTION OF PROTEINS ON
2-D GEL
In-gel digestion was performed using modified proto-
cols.21,22 We collected the same protein spots from
multi gels as required. For LC-MSMS, Coomasie
blue-stained spots of interest were excised from 2-D
gels (small amounts of spots were collected from
multi gels) and incubated 3 to 5 times with 50 mM
ammonium carbonate in methanol for destaining.
The gel pieces were digested in a buffer containing
100 mM ammonium bicarbonate and 5 ngμl of modi-
fied sequencing grade trypsin (Promega, Madison,
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Fig. 2 Immunolabeling with sera from patients MT, AO, SH, and control 
serum. Molecular weight standards (MW) are shown on the left.
Immunolabeling Patient MT
Immunolabeling Patient AO Immunolabeling Patient SH
Immunolabeling Control YT
94.4 kD
66.2 kD
45.0 kD
31.0 kD
21.5 kD
14.4 kD
WI, USA). After digestion, the resultant peptides
were extracted 3 times each, by sonication for 20 min-
utes. The extraction was carried out in buffer contain-
ing trifluoroacetic acid (TFA, 0.1%) and acetonitrile
(5%, 50%, and 95%). Finally, solutions were collected
and dehydrated in a centrifugal vaporizer. Proteins
were digested in the same way for MALDI-TOFMS.
After digestion, peptide extraction was carried out us-
ing sonication in 50% acetonitrile and 1% formic acid.
Sonication was performed twice for 10 minutes at
each replication and the resulting supernatant was re-
covered. Collected solutions were concentrated and
immediately used for MALDI-TOFMS.
LC-MSMS ANALYSIS
Each sample of peptides that had dried after in-gel di-
gestion was reconstituted in a reverse phase buffer A
containing acetonitrilewaterformic acid (5 : 95 : 0.1,
vvv) and subsequently transferred to a Shimadzu
auto-sampler (Shimadzu Corporation, Kyoto, Japan).
The LC-VP series HPLC system and MS analysis as
described previously was used for high-performance
LC-MS.23,24 Triple play scanning sequence data de-
pendent mode was used for Ion trap mass spectrome-
ter. The process from two-dimensional electrophore-
sis to MS was repeated and confirmed 3 times for
newly identified proteins. Raw data were converted to
a specific data format, and data analysis was con-
ducted to identify protein performed automatically us-
ing Mascot sequence database-searching software
(Matrix Science, London, UK). All procedures con-
ducted for the 2D-electrophoresis and the LC-MS
MS analysis were repeated 3 times, and the repro-
ducibility was confirmed.
MALDI-TOFMS ANALYSIS
The MALDI-TOFMS analysis method used here
was modified as described previously.22,25 The di-
gests were dissolved in 0.1% TFA and saturated α-
cyano-4-hydroxycinnamic acid solution (in 50% ace-
tone, 0.03% TFA) was used as the matrix. The matrix
solution was spotted onto an Anchortip (Bruker-
Franzen Analytic, Bremen, Germany), and the ana-
lyte solution was deposited. TFA (0.1%) was added
onto these depositions and then removed immedi-
ately. The α-cyano-4-hydroxycinnamic acid solution
(0.1 mgml) dissolved in 60% EtOH, 30% acetone, and
0.01% TFA was used for recrystallization. Data acqui-
sition and analysis was performed using flex control
and flex analysisbiotools version 2.2 software, re-
spectively.
RT-PCR FOR LIPOCALIN-TYPE PROSTAGLANDIN
D SYNTHASE (L-PGDS) EXPRESSION
Total RNA was extracted from the magnum of white
leghorn using the Isogen RNA Isolation kit (Nippon
Gene, Tokyo, Japan). Total RNA (5 μg) was used for
the synthesis of first-strand cDNA (called L-PGDS).
IgE Binding Proteins in Hen Egg Whites
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Table 2 Reactivities of 2-D spots to sera IgE. 2-D spots immunolabeled by sera from 19 patients and 11 controls
Spot No.
5650＊49484746373330292827252419181712765＊4＊3＊21＊
+++++++++++SH
++++++++++SK
++++++HS
+++++++++++++AOp
++++++RSa
++++++TEt
++++AKi
++KMe
+++++++RHn
++++++++++KKt
++AS
YY
+++MY
+++++KS
+++++MT
++++HM
+++++KS
+++++++++++SS
+++++++++RY
KH
++THc
++SYo
+++MKn
++KMt
TWr
YTo
ATl
TM
HM
++++++RH
553536316165 55162651616555521325353532174%P
0 92727 0 09180 0 00 0 09900 9 9 0 0 0 9 0%C
 Asterisks indicate significant diferences between egg alergy patients and controls by positive percentage.
The resulting cDNA was stored at -20℃ until use.
The oligonucleotide primer was synthesized by using
the following DNA sequences applied restriction
enzyme sites (EcoRI, SalI): EcoRI-PGDS primer: 5’-C
CGAATTCCATGCAAGCCACGCTGCTCSGC-3’; SalI-
PGDS primer: 5’-CCCCGTCGACCTAGGCAGCATCT
GCCATAC-3’.
PCR was performed in a 50 μl final reaction volume
containing 1 μl cDNA, 0.5 μM of each sense and an-
tisense primers, 0.2 mM of each dNTP, PCR 1 ×
buffer, 1.25 U of Pyrobest DNA polymerase (Takara,
Shiga, Japan). The resulting PCR product was cloned
into the pGEX6P-3 vector (Amersham, Piscataway,
NJ, USA). Cloned L-PGDS was sequenced by an ABI
Prism 310NT Genetic Analyzer.
PURIFICATION OF RECOMBINANT L-PGDS
Cloned L-PGDS was expressed as a glutathione S-
transferase fusion protein in BL21 E.coli. The recom-
binant fusion protein was purified from bacterial
lysates by affinity chromatography using Glutathione
Sepharose 4B (Amersham, Uppsala, Sweden) and the
glutathione S-transferase fusion tag was removed by
PreScission Protease cleavage (Amersham, Pis-
cataway, NJ, USA).
IMMUNOLABELING OF CYSTATIN AND RECOM-
BINANT L-PGDS WITH SERA FROM PATIENTS
AND CONTROLS
Cystatin (SIGMA, St. Louis, MO, USA) and recombi-
nant L-PGDS were separated by SDS-PAGE using a
13% or 12% separation gel. Five hundred nanograms
(ng) of cystatin or 1 μg of recombinant L-PGDS was
applied to each well. Each electroblotted membrane
was stained with Ponceau S or CBB and then immu-
nolabeled as described above.
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Table 3 Identification of egg white protein using LC-MS/MS and MALDI-TOF/MS analysis
Method †Determined SequenceAccession No.Protein DescriptionSpot
MALDI-TOF/MSSDFHLFGPPGKKgi|229552Ovotransferin 1
KDSNVNWNNLK
IQWCAVGKDEK
DLLFKDSAILMK
KGTEFTVNDLQGK
SAGWNIPIGTLLHR
FFSASCVPGATIEQK
TDERPASYFAVAVAR
NAPYSGYSGAFHCLK
DDNKVEDIWSFLSK
GAIEWEGIESGSVEQAVAK
ECNLAEVPTHAVVVRPEK
TGTCNFDEYFSEGCAPGSPPNSR
WSVVSNGDVECTVVDETKDCIK
HTTVNENAPDQKDEYELLCLDGSR
LKPIAAEVYEHTEGSTTSYYAVAVVKK
IMKGEADAVALDGGLVYTAGVCGLVPVMAER
LC-MS/MSEVSPTAMAIFRgi|20178282Ch21 protein28
ERNYTDEMVAVLPSQEECSVDEV
ISFLGEDELEVSYAAPSPK
LC-MS/MSSTGSSNMVLLYSRgi|45383612Lipocalin-type
prostaglandin
D synthase
29
MCTTDIAVTADGNMEVTSTYPK
LC-MS/MSVTLYYQQGCTSALMCGRERgi|45383131HEP21 protein43
TSLGKVTLYYQQGCTSALNCGR
LC-MS/MSVTLYYQQGCTSALMCGRERgi|45383131HEP21 protein45
TSLGKVTLYYQQGCTSALNCGR
VATVSLPR
YSCCETDLCNEK
LC-MS/MSALQFAMAEYNRgi|118195Cystatin49
LLGAPVPVDENDEGLQR
MALDI-TOF/MSFESNFNTQATNRgi|1065027Lysozyme mutant 
with Trp 62 
replaced by Tyr
50
IVSDGNDMNAWVAWR
NTDGSTDYGILQINSR
NLCNIPCSALLSSDITASVNCAK
NTDGSTDYGILQINSRYWCNDGR
† Protein spots analyzed and identified using either LC-MS/MS or MALDI-TOF/MS.
RESULTS
ELECTROPHORETIC PROFILES OF EGG WHITE
ALLERGENS
In preliminary studies, the number of egg white pro-
teins on pH3-10 non-linear 2-D gels was greater than
that of pH4-7 2-D gels; routine analysis was thus per-
formed on the former. In 2-D gel stained by CBB, the
number of protein spots was 30 (unpublished data),
whereas 63 were observed on silver-stained 2-D gels
(Fig. 1).
Protein spots were immunolabeled with serum IgE
from both patients with egg allergy and control sub-
jects. Representative immunoblot results are shown
in Figure 2. Twenty-five of the 63 spots observed by
silver staining reacted with patient sera. Fifteen of
these spots (nos. 1, 3, 4, 5, 12, 17, 24, 25, 27, 28, 29,
30, 46, 47, and 56) specifically reacted with patients’
sera, although spots no. 12, 17, 27, 30, and 56 showed
IgE-reaction only to a single serum (Table 2). Ten
spots (nos. 2, 6, 7, 18, 19, 33, 37, 48, 49, and 50) re-
acted with both control and patients’ serum IgE. Al-
though spot no. 50 was detected in more than half of
the patients, only one control subject was positive.
The unknown 38 spots (nos. 8-11, 13-16, 20-23, 26, 31,
32, 34-36, 38-45, 51-55, 57-63) did not react with either
control or patient serum IgE.
IDENTIFICATION OF IgE-REACTIVE SPOTS
To identify IgE-reactivity, spots were excised, di-
IgE Binding Proteins in Hen Egg Whites
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Fig. 3 Immunolabeling of recombinant L-PGDS with sera 
from patients and controls. Molecular weight standards 
(MW) are shown on the left. Patient, SH; Control, TM.
Immunolabeling
CBB Stain
MW
97.4 kD
66.2 kD
45 kD
31 kD
21.5 kD
14.4 kD
Lane
Patient Control
1 2 3 4
gested in-gel with trypsin, and the resulting peptide
mixtures were analyzed by LC-MSMS or MALDI-
TOFMS. Table 3 shows the peptides identified for
each protein.
Spot no. 1 reacted with 74% and spot no. 50 reacted
with 53% of the egg allergy patients; confirmed as
ovotransferrin and lysozyme, respectively. These re-
sults have been previously reported.6 Moreover, we
could confirm that reactivity to Ovomucoid (OM) in
this study corresponded to the OM-specific Immuno-
CAP (unpublished data). Spots no. 43 and 45, which
had no reactivity to IgE, were both identified as
HEP21. We showed for the first time that spots no. 28
and 29, also known as ch21 and lipocalin-type
prostaglandin D synthase (L-PGDS), respectively, re-
acted with IgE from patients with egg allergy. We
also show that spot no. 29 reacted with 16% of pa-
tients with egg allergy (including one patient with
systemic anaphylaxis). Finally, spot no. 49 showed as
high reactivity as lysozyme mutant activity with Trp
62 being replaced by Tyr in the sera of 53% of the pa-
tients, which was identified as cystatin. Patient YY did
not react to any spots other than OA.
IMMUNOLABELING OF RECOMBINANT L-PGDS
AND PURIFIED CYSTATIN
We confirmed whether recombinant L-PGDS and cys-
tatin of allergen candidates in this study react with se-
rum from egg allergy patients by purification of egg
white proteins. Figure 3 and 4 show that L-PGDS and
cystatin bind to IgE from egg allergy patients.
DISCUSSION
We set out to determine whether novel egg white
proteins reacted with IgE in patients with egg allergy
and identified the proteins by conducting 2-D immu-
nolabeling and mass spectrometric analysis. Re-
cently, new allergens have been demonstrated from
sesame seeds, Japanese cedar pollen, shrimp, etc.,
using 2-D immunolabeling in combination with
MALDI-TOFMS.15-18 These reports have found that
the combination of 2-D immunolabeling and mass
analysis effectively identifies new allergens. We were
able to perform this study using a proteomic method
and the LC-MSMS system.23 The LC-MSMS sys-
tem used in the present study has already been veri-
fied by us in an earlier experimental report.24 Al-
though Guérin-Dubiard et al.5 reported the identifica-
tion of 67 spots in egg white by multiple immobilized
pH gradient 2D gels, we were able to reveal 63 spots
using one gel (pH3-10NL 2-D gel) and silver staining.
In examinations, it is important that multiple proteins
can be analyzed using one gel.
2-D-immunoblot results indicated that many pro-
teins in egg white react with IgE in serum. The 25
spots that reacted with patients’ sera could be aller-
gen candidates. We demonstrated that spots no. 1
(ovotransferrin) and 50 (lysozyme) reacted more in-
tensively with serum from patients with egg allergy
compared to controls; and these 2 have already been
reported as major allergens.6 We also revealed, for
the first time, IgE-reactivity to ch21 protein, L-PGDS,
and egg white cystatin on 2-D gel. Reaction to L-
PGDS and cystatin was confirmed using each purified
protein.
Ch21 protein and L-PGDS belong to the lipocalin
family,26 which has been reported as allergenic.27,28
Ch21 protein and L-PGDS were minor allergens.
However, the sera from patient MT, which reacted to
spot no. 28 did not seem to react to the major spots,
such as nos. 3, 4, 5, 48, or 49. Patient HS did not react
to nos. 3, 4, 5 spots, either. This may increase the
possibility that the newly identified allergens are not
only the hidden allergen components, but there are
some patients who are preferentially reacting to those
minor egg allergens. Previous reports show that be-
ing a minor allergen does not always mean that it is
allergenically poor.29,30 Tomato profilin Lyc e 1,
which is a minor allergen, induces histamine re-
lease.29 These reports suggest that minor allergens
are targets for desensitizing treatments. Urade et al.
reported that PGD2 synthesized by L-PGDS is related
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Fig. 4 Immunolabeling of cystatin with sera from patients and controls. Molecular weight standards (MW) are shown on 
the left. Lane 1, control YT; lane 2, patient SS; lane 3, patient KM; lane 4, patient KK; lane 5, patient KS; lane 6, patient 
AK; lane 7, patient AO; lane 8, AS; lane 9, patient SH.
Ponceau staining Immunolabeling
(kD)
94.4
66.2
45
31
1 2 3 4 5 6 7 8 9
21.5
14.4
to allergic inflammation in vivo and that L-PGDS from
chicken shows PGDS activity.31,32 These reports sug-
gest that L-PGDS induces allergic reactions in addi-
tion to binding to IgE, and that PGD2 may exist in
eggs.
Cystatin has been reported to be a cysteine pro-
tease inhibitor, and is an allergen in cats and
dogs.33-35 Cystatin was considered to be a major aller-
gen because it showed high reactivity to IgE from pa-
tients with egg allergy. There are two possible rea-
sons for the lack of literature on cystatin as an aller-
gen. First, the similarity in molecular weight of cysta-
tin and Lysozyme, a major allergen, makes it difficult
to identify cystatin without using 2-D gel electropho-
resis. Further, the presence of only a small amount of
cystatin in eggs makes it difficult to identify without
development of LC-MSMS. Guérin-Dubiard et al.5
identified a spot as cystatin for the first time in 2006.
We demonstrated the reactivity of cystatin with IgE
from egg allergy patients using these developments
in technology.
IgE-reactivity profiles, including undefined proteins
in egg white, are shown in Table 2. The data and
methods here will provide guidance in determining
the sensitivity of individual patients to certain protein
or combination of proteins. Such information will be
useful for making more accurate diagnoses and
patient-tailored desensitizing treatments. Many stud-
ies on egg allergens have been performed using puri-
fied egg allergens such as ovalbumin and ovomucoid.
However, some allergens may interact with each
other, other proteins or other components in eggs.
This may in turn relate to the degree of allergic in-
flammation.
In conclusion, we demonstrated for the first time,
using proteomic analyses, some novel egg white pro-
teins that bound to IgE. We also identified new aller-
gen candidates. Our proteomics-based analyses in
egg white will support the development of more accu-
rate diagnoses and patient-tailored therapies for egg
allergy sufferers.
ACKNOWLEDGEMENTS
We appreciate the excellent technical advice given to
us by J. Masuda (Shimadzu Corporation) and Thoru
Suzuki, PhD (Genetic Engineering, Gifu University
Graduate School of Agricultural Science). We thank
Shigeru Ohtani, PhD (Laboratory of Animal Feeding
and Nutrition, Faculty of Applied Biological Sciences,
Gifu University) for provision of magnum from white
leghorn.
REFERENCES
1. Sampson HA. Update on food allergy. J Allergy Clin Im-
munol 2004;113:805-19.
2. Crespo JF, Pascual C, Burks AW, Helm RM, Esteban
MM. Frequency of food allergy in pediatric population
from Spain. Pediatr Allergy Immunol 1995;6:39-43.
3. Hefle SL. The chemistry and biology of food allergens.
Food Technol 1996;50:86-92.
4. Sampsom HA. Food Allergy. Part 1: immunopathologene-
sis and clinical disorders. J Allergy Clin Immunol 1999;
103:717-28.
5. Guérin-Dubiard C, Pasco M, Molle D, Desert C, Croguen-
nec T, Nau F. Comparison of different electrophoretic
separation of hen egg white proteins. J Agric Food Chem
2006;54:3901-10.
6. Holen E, Elsayed S. Characterization of four major aller-
gens of hen egg-white by IEFSDS-PAGE combined with
electrophoresis transfer and IgE-immnoautoradiography.
Int Arch Allergy Immunol 1990;91:136-41.
7. Suzuki K, Inoue R, Sakaguchi H et al. The correlation be-
IgE Binding Proteins in Hen Egg Whites
Allergology International Vol 59, No2, 2010 www.jsaweb.jp 183
tween ovomucoid-derived peptides, human leucocyte anti-
gen class II molecules and T cell receptor-
complementarity determining region 3 compositions in
patients with egg-white allergy. Clin Exp Allergy 2002;32:
1223-30.
8. Walsh BJ, Barnett D, Burley RW, Elliot C, Hill DJ, How-
den MEH. New allergen from Hen’s egg white and egg
yolk. In vitro study of ovomucin, apovitellenin I and VI,
and phosvitin. Int Arch Allergy Appl Immunol 1988;87:81-
6.
9. Aebersold R, Mann M. Mass spectrometry-based pro-
teomics. Nature 2003;422:198-207.
10. Görg A, Weiss W, Dunn MJ. Current two-dimensional
electrophoresis technology for proteomics. Proteomics
2004;4:3665-85.
11. Patterson SD, Aebersold R. Mass spectrometric ap-
proaches for the identification of gel-separated proteins.
Electrophoresis 1995;16:1791-814.
12. Cullen PA, Cordwell SJ, Bulach DM, Haake DA, Adler B.
Global analysis of outer membrane proteins from Lep-
tospira interrogans serovar Lai. Infect Immun 2002;70:
2311-8.
13. Lewis TS, Hunt JB, Aveline LD et al. Identification of
novel MAP kinase pathway signaling targets by functional
proteomics and mass spectrometry.Mol Cell 2000;6:1343-
54.
14. Beyer K, Bardina L, Grishina G, Sampson HA. Identifica-
tion of sesame seed allergens by 2-dimensional proteom-
ics and Edman sequencing: seed storage proteins as com-
mon food allergens. J Allergy Clin Immunol 2002;110:154-
9.
15. Fujimura T, Shigeta S, Kawamoto S et al. Two-
dimensional IgE-binding spectrum of Japanese Cedar
(Cryptomeria japonica) pollen allergens. Int Arch Allergy
Immunol 2004;133:125-35.
16. Yu CJ, Lin YF, Chiang BL, Chow LP. Proteomics and im-
munological analysis of a novel shrimp allergen, Pen m 2.
J Immunol 2003;170:445-53.
17. Yagami T, Haishima Y, Tsuchiya T, Tomitaka-Yagami A,
Kano H, Matsunaga K. Proteomic analysis of putative la-
tex allergens. Int Arch Allergy Immunol 2004;135:3-11.
18. Connolly JP, Comerci D, Alefantis TG et al. Proteomic
analysis of Brucella abortus cell envelope and identifica-
tion of immunogenic candidate proteins for vaccine devel-
opment. Proteomics 2006;6:3767-80.
19. Walz A, Mujer CV, Connolly JP et al. Bacillus anthracis
secretome time course under host-simulated conditions
and identification of immunogenic proteins. Proteome Sci
2007;5:11.
20. Shinoda S, Kondo N, Fukutomi O et al. Suppressive ef-
fects of elimination diets on T cell responses to ovalbumin
in hen’s egg-sensitive atopic dermatitis patients. Clin Exp
Allergy 1993;23:689-95.
21. Laemmli UK. Cleavage of structural proteins during as-
sembly of the head of bacteriophage T4. Nature 1970;
227:680-5.
22. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectro-
metric sequencing of proteins from silver-stained poly-
acrylamide gels. Anal Chem 1996;68:850-8.
23. Masuda J, Maynard DM, Nishimura M, Ueda T, Kowalak
JA, Markey SP. Fully automated micro- and nanoscale
one- or two-dimensional high-performance liquid chroma-
tography system for liquid chromatography-mass spec-
trometry compatible with non-volatile salts for ion ex-
change chromatography. J Chromatogr A 2005;1063:57-
69.
24. Fujigaki H, Saito K, Lin F et al. Nitration and inactivation
of IDO by peroxynitrite. J Immunol 2006;176:372-9.
25. Gobom J, Schuerenberg M, Muller M, Theiss D, Lehrach
H, Nordhoff E. Alpha-cyano-4-hydroxycinnamic acid affin-
ity sample preparation. A protocol for MALDI-MS peptide
analysis in proteomics. Anal Chem 2001;73:434-8.
26. Pagano A, Crooijmans R, Groenen M et al. A
chondrogenesis-related lipocalin cluster includes a third
new gene, CALγ. Gene 2003;305:185-94.
27. Konieczy A, Morgenstern JP, Bizinkauskas CB et al. The
major dog allergens, Can f 1 and Can f 2, are salivary
lipocalin proteins: cloning and immunological characteri-
zation of the recombinant forms. Immunology 1997;92:
577-86.
28. Mäntyjärvi R, Rautiainen J, Virtanen T. Lipocalins as aller-
gens. Biochem Biophys Acta 2000;1482:308-17.
29. Westphal S, Kempf W, Foetisch K, Retzek M, Vieths S,
Scheurer S. Tomato profilin Lyc e1: IgE cross-reactive
and allergic potency. Allergy 2004;59:526-32.
30. Wallowitz ML, Chenw RJY, Tzenw JTC, Teuber SS. Ses i
6, the sesame 11S globulin, can activate basophils and
shows cross-reactivity with walnut in vitro. Clin Exp Al-
lergy 2007;37:929-38.
31. Fujitani Y, Kanaoka Y, Aritake K, Uodome N, Okazaki-
Hatake K, Urade Y. Pronounced eosinophilic lung inflam-
mation and Th2 cytokine release in human lipocalin-type
prostaglandin D synthase transgenic mice. J Immunol
2002;168:443-9.
32. Fujimori K, Inui T, Uodome N, Kadoyama K, Aritake K,
Urade Y. Zebrafish and chicken lipocalin-type
prostaglandin D synthase homologues: conservation of
mammalian gene structure and binding ability for lipo-
philic molecules, and difference in expression profile and
enzyme activity. Gene 2006;375:14-25.
33. Sen LC, Whitaker JR. Some properties of a ficin-papain in-
hibitor from avian egg white. Arch Biochem Biophys 1973;
158:623-32.
34. Van’t hof W, Blankenvoorde MFJ, Veerman ECI, Ameron-
gen AVN. The salivary lipocalin von Ebner’s gland protein
is a cystein proteinase inhibitor. J Biol Chem 1997;272:
1837-41.
35. Ichikawa K, Vailes LD, Pomes A, Chapman MD. Identifi-
cation of a novel cat allergen-cystatin. Int Arch Allergy Im-
munol 2001;124:55-6.
